0001585608-21-000003.txt : 20210326 0001585608-21-000003.hdr.sgml : 20210326 20210325212226 ACCESSION NUMBER: 0001585608-21-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210326 DATE AS OF CHANGE: 20210325 EFFECTIVENESS DATE: 20210326 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Jaguar Health, Inc. CENTRAL INDEX KEY: 0001585608 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-393615 FILM NUMBER: 21774354 BUSINESS ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-371-8300 MAIL ADDRESS: STREET 1: 200 PINE STREET SUITE 400 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 FORMER COMPANY: FORMER CONFORMED NAME: Jaguar Animal Health, Inc. DATE OF NAME CHANGE: 20130830 D 1 primary_doc.xml X0708 D LIVE 0001585608 Jaguar Health, Inc. 200 PINE STREET SUITE 400 SAN FRANCISCO CA CALIFORNIA 94104 415-371-8300 DELAWARE Jaguar Animal Health, Inc. Corporation true Lisa Conte 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Executive Officer Director Promoter Carol Lizak 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Executive Officer Steven King 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Executive Officer Jonathan Wolin 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Executive Officer James Bochnowski 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Director John Micek, III 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Director Greg J. Divis 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Director Jonathan B. Siegel 200 Pine Street, Suite 400 San Francisco CA CALIFORNIA 94104 Director Pharmaceuticals Decline to Disclose 06b false 2021-03-08 false true true Royalty interest. false 0 10000000 10000000 0 Issuer sold royalty interest entitling investor to receive $10 million in future royalties for an aggregate purchase price of $5 million. false 1 0 0 0 false Jaguar Health, Inc. /s/ Lisa Conte Lisa Conte Chief Executive Officer 2021-03-17